Saniona Competitors or Alternatives

Saniona's top competitors include OptiNose, Curemark and Neurim Pharmaceuticals.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Saniona's company profile

Rami Levin

President & CEO

89/100
34
$10M
$1.3M
1
Saniona's Competitor - OptiNose logo

Ramy A. Mahmoud

CEO

85/100
190
$583.6M
$78.2M
2
Saniona's Competitor - Curemark logo

Joan Fallon

Founder & CEO

91/100
25 - 100
$76.1M
$5M - 25M
3
Saniona's Competitor - Neurim Pharmaceuticals logo

Nava Zisapel

Co-Founder & CEO

90/100
25 - 100
- -
$5M - 25M
4
Saniona's Competitor - Promentis logo

Klaus Veitinger

CEO

76/100
25 - 100
$63M
$5M - 25M
5
Saniona's Competitor - Bionomics logo

Spyros Papapetropoulos

President & CEO

82/100
24
$44.9M
$ < 1M

Saniona VS OptiNose

OptiNose is the top competitor of Saniona. OptiNose is a Public company that was founded in Bucks County, Pennsylvania in 2000. Like Saniona, OptiNose also operates in the Pharmaceuticals sector. OptiNose has 156 more employees vs. Saniona.

Saniona VS Curemark

Curemark is seen as one of Saniona's biggest rivals. Curemark was founded in Rye Brook, New York} in 2004. Like Saniona, Curemark also competes in the Pharmaceuticals & Biotechnology space. Compared to Saniona, Curemark generates $3.7M more revenue.

Saniona VS Neurim Pharmaceuticals

Neurim Pharmaceuticals is perceived as one of Saniona's biggest rivals. Neurim Pharmaceuticals was founded in 1991, and is headquartered in Tel Aviv, Tel Aviv District. Like Saniona, Neurim Pharmaceuticals also operates in the Pharmaceuticals space. Neurim Pharmaceuticals generates $11M more revenue vs. Saniona.

Frequently Asked Questions about Saniona

  1. Who are Saniona's top competitors?

    Saniona's top 3 competitors are OptiNose, Curemark, Neurim Pharmaceuticals.
  2. Who is similar to Saniona?

    OptiNose is the most similar to Saniona. Curemark and Neurim Pharmaceuticals are also similar to Saniona.
  1. Are Saniona and OptiNose competitors?

    Yes, OptiNose is one of Saniona’s top competitors.